CJC-1295 (No DAC)
≥99% purity verified by independent HPLC and mass spectrometry (MS) through Janoshik Analytical. Intended for laboratory research use only; not for human consumption, diagnosis, or treatment. View transparency report
Documentation & standards
- Peptide Purity Verification: Turning a Claim Into Evidence
- How to Read a Peptide Certificate of Analysis (COA)
- Peptide Storage and Handling: Temperature, Light and Stability
Synthetic GHRH analog without DAC, studied in growth hormone signaling research.
Mix and match any items — discount applies automatically at checkout.
Reminder email when it's time to reorder. No card on file. Cancel anytime from your account — or email support@aresresearchlab.com.
Earn 34 loyalty points on this purchase · 100 pts = $5 off
Create a Research Account to unlock full batch data, COAs, and priority releases.
Intended strictly for research and laboratory use only. Not for human consumption.
About CJC-1295 (No DAC)
Third-party purity testing available upon request.
Research Classification
Storage Information
CJC-1295 (No DAC) Purity & COA Verification
For laboratory research use only. Not for human consumption, diagnosis, or treatment.
CJC-1295 (No DAC) research questions
+What purity is CJC-1295 (No DAC) supplied at?
Every batch is manufactured to ≥99% purity and verified by HPLC and mass spectrometry, with a public batch COA on the product page.
+What is the difference between CJC-1295 with and without DAC?
CJC-1295 without DAC (Mod GRF 1-29) has a short half-life measured in minutes and is studied for pulsed GH signaling; the DAC variant binds serum albumin and extends half-life to roughly 8 days. See /compare/cjc-1295-dac-vs-cjc-1295-no-dac.
+How is CJC-1295 (No DAC) reconstituted?
Reconstitute with bacteriostatic water added slowly against the vial wall. Swirl gently until fully dissolved; do not shake.
+Is CJC-1295 (No DAC) intended for human use?
No. It is supplied strictly for laboratory research use only.
Read the CJC-1295 (No DAC) research
Research-only pharmacokinetic profile of CJC-1295: serum half-life, Tmax, route comparisons, clearance and bioavailability — curated from published preclinical and clinical PK literature.
Read article →Recombinant HGH vs CJC-1295/Ipamorelin stack: exogenous vs endogenous GH release, pulsatility, safety profile and cost.
Read article →A research-context comparison of CJC-1295 with and without the Drug Affinity Complex modification — pharmacokinetics, GH secretion patterns, and the implications for pulsatility.
Read article →Published benefits, side effects, and DAC vs no-DAC comparisons for CJC-1295 — the stabilized GHRH(1-29) analog with two distinct research profiles.
Read article →GHRH analog (CJC-1295) vs GHRP (Ipamorelin) — side-by-side research comparison of mechanism, half-life, and why the two are commonly studied together.
Read article →Side-by-side comparison of CJC-1295 and sermorelin — two GHRH-analog research peptides — covering mechanism, half-life, pulsatility, and published research data.
Read article →How Ares compares for CJC-1295 (No DAC)
Independent, documentation-first breakdowns of the vendors researchers most often ask about for this compound. COA verification, US shipping, and sourcing transparency, side by side.
Frequently bought together
Curated complements for this compound — researchers most often pair it with these.
Research Use Disclaimer
Researcher Reviews
Sign in with the account that placed your order to leave a verified review.
Ask the Lab
No public questions yet — be the first to ask.
All testing documentation and COA data are provided for laboratory research use only and are not intended to support human consumption, diagnostic, or therapeutic use.
Independent Certificate of Analysis
Independently tested by In-House Verification. Verified and batch-tracked by Ares Research. Additional reports available upon request.
No fillers. No shortcuts. Only verified compounds.
More from Growth Hormone
CJC-1295 (No DAC) vs…
Researchers often weigh CJC-1295 (No DAC) against these alternatives. Spec-by-spec breakdowns: